COMPASS Pathways plc(NASDAQ:CMPS) 
COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin formulation, which is in Phase IIb clinical trial to treat patients with treatment-resistant depression. The company was formerly known as COMPASS Rx Limited a...
Website: https://compasspathways.com/
Founded: 2016
CEO: George Goldsmith
Sector: Other
Industry: Other
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 2.76
H 2.77
L 2.56
C 2.71
V 1,500,245
10EMA 2.71
20EMA 2.71
60EMA 2.71
120EMA 2.71
250EMA 2.71